World Fusion is the leading Bio- and Chem- informatics company in Japan. Since 1996, World Fusion has been developing various bioinformatics tools for Japanese researchers. We have been involved in many projects, such as "human genome projects", "genome wide association studies", and "proteome projects" in Japan, and those experiences have kept us at the top of the Japanese bioinformatics scene. More recently we have been focusing on therapetic target discovery, gene expression analysis, variant analysis, and developing metagenomic and metatranscriptomic data analysis tools.
Over 50 pharmaceutical companies, and several hundred academic and government researchers in Japan use our products and services. We support everything from basic research to large projects such as GWAS, and also support many types of drug discovery projects and biomarker research.
We continually seek and develop new technologies with future trends in mind:
Advanced analysis techniques of bioinformatics and chemoinformatics
Know-how of handling public databases, and knowledge of how that information can be used effectively for data analysis—such as microarrays or next generation sequencing
Creating keyword dictionaries from public databases including chemical structures
Techniques for discovering target genes using disease model animals
Engineering techniques for the creation of our knowledge database for the field of drug discovery
KOZO KAWAHARA, CEO/PRESIDENT
World Fusion Co., Ltd
2-15-15 Shinsendo Bldg.7th Floor, Nihonbashi Ningyo-cho, Chuo-ku, Tokyo, Japan 103-0013
TEL: +81-3-3662-0521 FAX: +81-3-3662-0522
World Fusion US, Inc
4025 Camino Del Rio South, Suite 300,
San Diego, CA 92108